Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo

Toshiyuki Kozai, Hiroaki Shimokawa, Yoshihiro Fukumoto, Sei Kobayashi, M. Koji Owada, Toshiaki Kadokami, Akira Ito, Kouichi Kuwata, Kensuke Egashira, Tadayoshi Shiraishi, Hideo Kanaide, Akira Takeshita

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Platelet-derived growth factor (PDGF) plays an important role in the development of coronary atherosclerosis. However, it remains to be examined what morphologic and functional changes are induced in vivo by the long-term treatment with PDGF itself or what pharmacologic interventions could suppress those changes in vivo. Our study was designed to address these points. We examined the effects of long-term treatment with PDGF on the porcine coronary artery in vivo. Under aseptic conditions, the proximal segments of the left porcine coronary artery were gently wrapped with cotton mesh absorbing sepharose beads either with or without recombinant human PDGF-AA or -BB. Two weeks after the operation, coronary hyperconstrictions to intracoronary serotonin or histamine were noted at the sites treated with PDGF-AA or -BB. Histologically, neointimal formation and geometric remodeling (reduction of the total vessel area) were noted at the PDGF-treated sites. These functional and histologic changes of the coronary artery induced by PDGF were markedly inhibited by cotreatment with ST 638, a specific inhibitor of tyrosine kinases. A Western blot analysis showed that ST 638 markedly suppressed the PDGF-induced tyrosine phosphorylations in the coronary segment. These results indicate thai long-term treatment with PDGF induces neointimal formation, geometric remodeling, and vasospastic responses in vivo, for all of which, activation of tyrosine kinases is substantially involved.

Original languageEnglish
Pages (from-to)536-545
Number of pages10
JournalJournal of Cardiovascular Pharmacology
Volume29
Issue number4
DOIs
Publication statusPublished - Apr 1 1997

Fingerprint

Platelet-Derived Growth Factor
Protein-Tyrosine Kinases
Swine
Coronary Vessels
Sepharose
Histamine
Tyrosine
Coronary Artery Disease
Serotonin
Western Blotting
Phosphorylation

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo. / Kozai, Toshiyuki; Shimokawa, Hiroaki; Fukumoto, Yoshihiro; Kobayashi, Sei; Owada, M. Koji; Kadokami, Toshiaki; Ito, Akira; Kuwata, Kouichi; Egashira, Kensuke; Shiraishi, Tadayoshi; Kanaide, Hideo; Takeshita, Akira.

In: Journal of Cardiovascular Pharmacology, Vol. 29, No. 4, 01.04.1997, p. 536-545.

Research output: Contribution to journalArticle

Kozai, Toshiyuki ; Shimokawa, Hiroaki ; Fukumoto, Yoshihiro ; Kobayashi, Sei ; Owada, M. Koji ; Kadokami, Toshiaki ; Ito, Akira ; Kuwata, Kouichi ; Egashira, Kensuke ; Shiraishi, Tadayoshi ; Kanaide, Hideo ; Takeshita, Akira. / Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo. In: Journal of Cardiovascular Pharmacology. 1997 ; Vol. 29, No. 4. pp. 536-545.
@article{967f2c1c3f624b25ba0f3f2206055bc7,
title = "Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo",
abstract = "Platelet-derived growth factor (PDGF) plays an important role in the development of coronary atherosclerosis. However, it remains to be examined what morphologic and functional changes are induced in vivo by the long-term treatment with PDGF itself or what pharmacologic interventions could suppress those changes in vivo. Our study was designed to address these points. We examined the effects of long-term treatment with PDGF on the porcine coronary artery in vivo. Under aseptic conditions, the proximal segments of the left porcine coronary artery were gently wrapped with cotton mesh absorbing sepharose beads either with or without recombinant human PDGF-AA or -BB. Two weeks after the operation, coronary hyperconstrictions to intracoronary serotonin or histamine were noted at the sites treated with PDGF-AA or -BB. Histologically, neointimal formation and geometric remodeling (reduction of the total vessel area) were noted at the PDGF-treated sites. These functional and histologic changes of the coronary artery induced by PDGF were markedly inhibited by cotreatment with ST 638, a specific inhibitor of tyrosine kinases. A Western blot analysis showed that ST 638 markedly suppressed the PDGF-induced tyrosine phosphorylations in the coronary segment. These results indicate thai long-term treatment with PDGF induces neointimal formation, geometric remodeling, and vasospastic responses in vivo, for all of which, activation of tyrosine kinases is substantially involved.",
author = "Toshiyuki Kozai and Hiroaki Shimokawa and Yoshihiro Fukumoto and Sei Kobayashi and Owada, {M. Koji} and Toshiaki Kadokami and Akira Ito and Kouichi Kuwata and Kensuke Egashira and Tadayoshi Shiraishi and Hideo Kanaide and Akira Takeshita",
year = "1997",
month = "4",
day = "1",
doi = "10.1097/00005344-199704000-00016",
language = "English",
volume = "29",
pages = "536--545",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo

AU - Kozai, Toshiyuki

AU - Shimokawa, Hiroaki

AU - Fukumoto, Yoshihiro

AU - Kobayashi, Sei

AU - Owada, M. Koji

AU - Kadokami, Toshiaki

AU - Ito, Akira

AU - Kuwata, Kouichi

AU - Egashira, Kensuke

AU - Shiraishi, Tadayoshi

AU - Kanaide, Hideo

AU - Takeshita, Akira

PY - 1997/4/1

Y1 - 1997/4/1

N2 - Platelet-derived growth factor (PDGF) plays an important role in the development of coronary atherosclerosis. However, it remains to be examined what morphologic and functional changes are induced in vivo by the long-term treatment with PDGF itself or what pharmacologic interventions could suppress those changes in vivo. Our study was designed to address these points. We examined the effects of long-term treatment with PDGF on the porcine coronary artery in vivo. Under aseptic conditions, the proximal segments of the left porcine coronary artery were gently wrapped with cotton mesh absorbing sepharose beads either with or without recombinant human PDGF-AA or -BB. Two weeks after the operation, coronary hyperconstrictions to intracoronary serotonin or histamine were noted at the sites treated with PDGF-AA or -BB. Histologically, neointimal formation and geometric remodeling (reduction of the total vessel area) were noted at the PDGF-treated sites. These functional and histologic changes of the coronary artery induced by PDGF were markedly inhibited by cotreatment with ST 638, a specific inhibitor of tyrosine kinases. A Western blot analysis showed that ST 638 markedly suppressed the PDGF-induced tyrosine phosphorylations in the coronary segment. These results indicate thai long-term treatment with PDGF induces neointimal formation, geometric remodeling, and vasospastic responses in vivo, for all of which, activation of tyrosine kinases is substantially involved.

AB - Platelet-derived growth factor (PDGF) plays an important role in the development of coronary atherosclerosis. However, it remains to be examined what morphologic and functional changes are induced in vivo by the long-term treatment with PDGF itself or what pharmacologic interventions could suppress those changes in vivo. Our study was designed to address these points. We examined the effects of long-term treatment with PDGF on the porcine coronary artery in vivo. Under aseptic conditions, the proximal segments of the left porcine coronary artery were gently wrapped with cotton mesh absorbing sepharose beads either with or without recombinant human PDGF-AA or -BB. Two weeks after the operation, coronary hyperconstrictions to intracoronary serotonin or histamine were noted at the sites treated with PDGF-AA or -BB. Histologically, neointimal formation and geometric remodeling (reduction of the total vessel area) were noted at the PDGF-treated sites. These functional and histologic changes of the coronary artery induced by PDGF were markedly inhibited by cotreatment with ST 638, a specific inhibitor of tyrosine kinases. A Western blot analysis showed that ST 638 markedly suppressed the PDGF-induced tyrosine phosphorylations in the coronary segment. These results indicate thai long-term treatment with PDGF induces neointimal formation, geometric remodeling, and vasospastic responses in vivo, for all of which, activation of tyrosine kinases is substantially involved.

UR - http://www.scopus.com/inward/record.url?scp=0030970339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030970339&partnerID=8YFLogxK

U2 - 10.1097/00005344-199704000-00016

DO - 10.1097/00005344-199704000-00016

M3 - Article

C2 - 9156365

AN - SCOPUS:0030970339

VL - 29

SP - 536

EP - 545

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 4

ER -